Validogen GmbH

https://www.validogen.com

VTU Technology, a leading contract research and development company, offers the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein production. VTU develops high performance expression strains and economically viable protein production processes for the manufacture of biopharmaceuticals, enzymes and various other recombinant proteins. Headquartered in Grambach/Graz, Austria, VTU Technology is a private company and a subsidiary of VTU Holding, an Austrian enterprise that combines several technology and engineering companies in chemistry, pharma & life science. The VTU group currently counts more than 420 highly qualified people working in several subsidiaries in different European countries. From 2013 to 2015, the VTU group was able to boost its turnover from 40 million euros to 72 million euros. *

Profile: VTU Technology is a leading contract research and development company providing services for the fast-track generation of high-performance industrial protein production strains and processes for pharma and life science companies and other protein manufacturers. VTU´s exclusive Pichia pastoris high-throughput platform which is based on its 1st and 2nd generation AOX1 promoter libraries is best suited for economic protein production furnishing expression titers of >10 g/L with up to 90% initial purity within a few weeks of development for a wide range of recombinant proteins including serum proteins, cytokines, Fabs and other antibody derived fragments, scaffold proteins, fusion proteins and enzymes.

Industry: Biotech

Products/Services: VTU applies its exclusive cutting-edge Pichia pastoris protein production platform and offers expertise and services, which span the entire range from gene to highly productive expression strains and and processes from lab to pilot scale, in minimum time.

Services:
– Gene design and cloning
– Development of customized high performance expression strains at unrivaled speed
– Confirmation of microscale screening results through cultivation in paralleled 1L-bioreactors
– Bioprocess development and process characterization
– Early stage manufacturing
– Sound technology transfer to our customers supporting regulatory filings

Employees: 15

Partners:
– ACIB (Austrian Center of Industrial Biotechnology)
– Boehringer Ingelheim
– Graz University of Technology, Austria
– University of Oxford, England

The organisation submitted the information to [MSC] on 13 September 2011.

	Start	2018-10-22 renamed
	Group	KonValue (Group)
	Predecessor	VTU Technology GmbH
	Industry	contract manufacturing (biologicals)
	Industry 2	Pichia yeast expression system
	Person	Purkarthofer, Thomas (VTU Technology 201412 Head Business Development)

	Region	Grambach
	Country	Austria
	Street	18 Parkring
	City	8074 Raaba-Grambach
	Tel	+43-316-4000
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-07-10